Joyce Zhou

Stock Analyst at J.P. Morgan

(0.92)
# 4,006
Out of 5,078 analysts
4
Total ratings
25%
Success rate
-12.2%
Average return

Stocks Rated by Joyce Zhou

Hemab Therapeutics Holdings
Oct 16, 2026
Initiated: Buy
Price Target: $70
Current: $32.52
Upside: +115.25%
Prelude Therapeutics
Sep 17, 2026
Initiated Coverage: Buy
Price Target: $12
Current: $3.32
Upside: +261.45%
Sohu.com
Mar 23, 2015
Reiterated: Buy
Price Target: n/a
Current: $12.61
Upside: n/a